Skip to content
healthcare.dev

Octreotide Acetate

NDC 0641-6176, Octreotide Acetate, injection, solution, from Hikma Pharmaceuticals USA Inc..

Product NDC
0641-6176
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076313
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6176 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OCTREOTIDE ACETATE500 ug/mL

Pharmacologic classes

Somatostatin Analog [EPC]; Somatostatin Receptor Agonists [MoA]

Package NDCNDC-11Package
0641-6176-100064161761010 VIAL, SINGLE-DOSE in 1 CARTON (0641-6176-10) / 1 mL in 1 VIAL, SINGLE-DOSE (0641-6176-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9502860d-0261-4d69-a4be-827a5376d356
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0641-6176

Use it

Look up 0641-6176 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6176 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0641-6176. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.